JABET Explore more articles

Table 2. Current update on clinical trials of LF.

 

Identifier No.

Types of diseases

Estimated enrollment

Primary purpose

Phase

 

NCT04094597

Neonatal sepsis

200 participants

Prevention

Early Phase 1

 

NCT03431558

Neonatal sepsis

Necrotizing enterocolitis

300 participants

Prevention

Phase 3

 

NCT03163212

Safety issues Tolerance

Very low birth weight infant

20 participants

Treatment

Early Phase 1

NCT04445948

Helicobacter pylori infection

400 participants

Treatment

Phase 4

 

NCT03481790

Iron deficiency anemia of pregnancy

200 participants

Treatment

Phase 2

 

NCT03202615

Anemia during pregnancy

130 participants

Treatment

Phase 4

 

NCT04267653

Iron deficiency anemia

96 participants

Treatment

Phase 4

 

NCT02959229

Neonatal sepsis

180 participants

Prevention

Phase 4

 

NCT04432935

Poliomyelitis

754 participants

Prevention

N/A

 

NCT01525316

Late-onset neonatal sepsis

414 participants

Prevention

Phase 3

 

NCT02626104

Antibiotic-associated diarrhoea

156 participants

Prevention

Phase 2

 

NCT01264536

Sepsis

190 participants

Prevention

Phase 2

 

NCT03866837

Iron-deficiency

288 participants

Treatment

N/A

 

NCT03367013

Preterm infant

Very low birth weight infant

Morbidity; newborn

500 participants

Prevention

Phase 3

 

NCT04435574

Anemia, iron deficiency

90 participants

Treatment

Phase 4

 

NCT01221844

Pregnancy

Iron deficiency

Iron deficiency anemia

300 participants

Treatment

Phase 4

 

NCT03940430

Iron deficiency anemia

90 participants

Treatment

Phase 3

 

NCT01266629

Crohn's disease

40 participants

 

N/A

 

NCT00429325

Acute diarrhea

400 participants

 

N/A

 

NCT00937014

Infant nutrition

180 participants

 

N/A

 

NCT03262402

HIV/AIDS

Periodontal diseases

22 participants

Treatment

N/A

 

NCT01700725

Persian-gulf syndrome

Chronic sinusitis

Fatigue

Acute sinusitis

40 participants

Treatment

Phase 2

 

NCT00630656

Severe sepsis

190 participants

Treatment

Phase 2